Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier

Linzhang Zhang(Shanghai University of Traditional Chinese Medicine), Wei Liu(Tianjin University of Traditional Chinese Medicine), Yongping Mu(Shanghai University of Traditional Chinese Medicine), Xiaoyu Jiang(Shanghai University of Traditional Chinese Medicine), Hua Zhang(Central South University), Ping Liu(Obstetrics and Gynecology Hospital of Fudan University), Jianwei Zhang(State Administration of Traditional Chinese Medicine of the People's Republic of China), Xiaoli Shi(Nanjing Drum Tower Hospital), Jiamei Chen(Shanghai University of Traditional Chinese Medicine), Gaofeng Chen(Shanghai University of Traditional Chinese Medicine), Shenglan Qi(State Administration of Traditional Chinese Medicine of the People's Republic of China), Jiewen Shi(Shanghai University of Traditional Chinese Medicine), Zhishen Xie(First Affiliated Hospital of Henan University)
Journal of Ethnopharmacology
July 31, 2024
10.1016/j.jep.2024.118649
Cited by 12

Related Papers

Pharmacological effects of Astragaloside IV: a literature review
|中医杂志：英文版|2013|263
Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage
|Frontiers in Pharmacology|2020|176
Progression and Regression of Chronic Kidney Disease by Age Among Adults in a Population-Based Cohort in Alberta, Canada
|JAMA Network Open|2021|93
Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine–choline-deficient diet
|Laboratory Investigation|2009|77
Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes
|Laboratory Investigation|2015|75